Oscar Health (OSCR) Other financing activities (2021 - 2026)

Oscar Health has reported Other financing activities for 5 years, with the latest figure at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $5.0 million (changed N/A YoY), and the FY2025 full-year result was $22.9 million, changed N/A from the prior year.
• Other financing activities for Q1 2026 stood at $4.7 million, up from $225000.0 in the prior quarter.
• The five-year high for Other financing activities was $6.8 million in Q2 2022, with the low at -$1000.0 in Q4 2023.
• Historically, Other financing activities has averaged $2.1 million across 4 years, with a median of $471000.0 in 2023.
• The largest YoY upside for Other financing activities was 88.4% in 2023 against a maximum downside of 88.4% in 2023.
• Oscar Health's Other financing activities stood at $6.8 million in 2022, then sank by 100.01% to -$1000.0 in 2023, then soared by 22600.0% to $225000.0 in 2025, then soared by 2006.22% to $4.7 million in 2026.
• The last three Other financing activities figures came in at $4.7 million (Q1 2026), $225000.0 (Q4 2025), and -$1000.0 (Q4 2023), per Business Quant data.